Your browser doesn't support javascript.
loading
First-line or second-line PD-1 inhibition in advanced oesophageal squamous cell carcinoma: A prospective, multicentre, registry study.
Li, Xu-Yuan; Huang, Li-Sheng; Cai, Hao-Quan; Huang, Wan-Lan; Huang, Xiao-Long.
Afiliación
  • Li XY; Department of Medical Oncology, Shantou Central Hospital, Shantou, China.
  • Huang LS; Department of Radiation Oncology, Cancer Hospital of Shantou University Medical College, Shantou, China.
  • Cai HQ; Department of Medical Oncology, the First Affiliated Hospital of Shantou University Medical College, Shantou, China.
  • Huang WL; Department of Medical Oncology, Jieyang People's Hospital, Jieyang, China.
  • Huang XL; Department of Medical Oncology, Puning People's Hospital, Puning, China.
J Clin Pharm Ther ; 47(6): 732-737, 2022 Jun.
Article en En | MEDLINE | ID: mdl-34974631
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Esofágicas / Carcinoma de Células Escamosas de Esófago / Neoplasias Pulmonares Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: J Clin Pharm Ther Asunto de la revista: FARMACIA / TERAPEUTICA Año: 2022 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Esofágicas / Carcinoma de Células Escamosas de Esófago / Neoplasias Pulmonares Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: J Clin Pharm Ther Asunto de la revista: FARMACIA / TERAPEUTICA Año: 2022 Tipo del documento: Article País de afiliación: China